Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy

Abstract Background To investigate the correlation between the thickness of epicardial adipose tissue (EAT), C-reactive protein (CRP), interleukin (IL) -6, visfatin, juxtaposed with another zinc finger protein 1 (JAZF1) and type 2 diabetic mellitus (T2DM) macroangiopathy. Methods The study enrolled 82 patients with T2DM with macroangiopathy (the Complication Group), and 85 patients with T2DM (the Diabetes Group) who were admitted to Shandong Provincial Third Hospital from February 2018 to February 2020. In addition, 90 healthy people who underwent physical examination at the same hospital during the same period were enrolled (the Healthy Control Group). Age, gender, height, weight, waist circumference (WC), hip circumference (HC), diabetic course and therapeutic drugs, waist hip ratio (WHR), and body mass index (BMI) were recorded and calculated. Results The baseline characteristics of the three groups were comparable, and the diabetic course of the Complication Group and the Diabetes Group was not significantly different (P > 0.05). The WHR of the Complication Group was higher than that of the Diabetes Group and the Healthy Control Group, with statistical significance (P < 0.05). The FPG, 2hPG, HbA1C, CRP, IL-6, Visfatin, JAZF1, HOMA-IR, EAT thickness, and baPWV of the Complication Group were all higher than those of the Diabetes Group and the Healthy Control Group (P < 0.05, respectively). The JAZF1 and FIns of the Complication Group and Diabetes Group were lower than those of the Healthy Control Group, and JAZF1 of the Complication Group was lower than the Diabetes Group with statistical significance (P<0.05, respectively). Pearson correlation analysis showed that the EAT thickness was positively correlated with CRP, IL-6, visfatin, and JAZF1 (r = 0.387, 0.451, 0.283, 0.301, respectively, all P<0.001). Pearson correlation analysis showed that baPWV was positively correlated with EAT thickness, CRP, IL-6, visfatin, and JAZF1 (r = 0.293, 0.382, 0.473, 0.286, respectively, all P < 0.001). Multivariate stepwise regression analysis showed that FPG, 2hPG, HbA1C, CRP, IL-6, visfatin, JAZF1, and EAT thickness were independent risk factors that affected T2DM macroangiopathy. Conclusions Clinical monitoring and treatment of T2DM macroangiopathy can use CRP, IL-6, Visfatin, JAZF1, and EAT thickness as new targets to delay the progression of the disease. Further research on the relationship between the above factors and the pathogenesis of T2DM macroangiopathy may be helpful provide new treatment strategies.

Download Full-text

Salivary Procalcitonin and Periodontitis in Diabetes

Journal of Dental Research ◽

10.1177/154405910808700707 ◽

2008 ◽

Vol 87 (7) ◽

pp. 630-634 ◽

Cited By ~ 18

Author(s):

C.W. Bassim ◽

R.S. Redman ◽

D.J. DeNucci ◽

K.L. Becker ◽

E.S. Nylen

Keyword(s):

Type 2 Diabetes ◽

Serum Levels ◽

Serum Marker ◽

Control Group ◽

Diabetes Group ◽

Severe Periodontitis ◽

Healthy Control ◽

First Time ◽

Morbid Conditions

Periodontitis and type 2 diabetes are co-morbid conditions, both characterized by infectious susceptibility. We investigated procalcitonin (ProCT) levels in the serum and saliva of persons with periodontitis and type 2 diabetes (n = 20), to determine if these levels are altered by periodontitis activity or by hyperglycemia. Persons with severe periodontitis showed higher levels of salivary-ProCT than did those with moderate periodontitis (241 ± 71 vs. 77 ± 516 pg/mL, p = 0.02) and higher levels than did healthy control individuals (118 ± 26 pg/mL, p = 0.05). Salivary-ProCT levels were correlated with bleeding-on-probing (r = 0.45, p = 0.05), as well as with HgbA1c (r = 0.49, p = 0.03). Salivary levels of ProCT were higher than serum levels for the periodontitis/diabetes group (152 ± 37 vs. 78 ± 17 pg/mL, p = 0.02) and the control group (118 ± 146 vs. 48 ± 17 pg/mL, p = 0.01). Persons with periodontitis and type 2 diabetes have salivary-ProCT levels that reflect their degree of periodontitis activity and hyperglycemia. This study demonstrates, for the first time, the presence of procalcitonin (ProCT), an established serum marker of infection, in saliva.

Download Full-text

Chemerin rs17173608 Gene Polymorphism is not Associated with Type 2 Diabetes Mellitus: a Cross-sectional Study

Folia Medica ◽

10.2478/folmed-2018-0045 ◽

2019 ◽

Vol 61 (1) ◽

pp. 69-75

Author(s):

Serdar Olt ◽

Orhan Öznas ◽

Haydar Bağış ◽

Eda Tahir Turanlı

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Gene Polymorphism ◽

Healthy Control Group ◽

Control Group ◽

Arms Pcr ◽

Significant Difference ◽

Healthy Control

Abstract Background: Previous studies have shown that chemerin has important roles in the development of obesity, insulin resistance, metabolic syndrome, polycystic ovary syndrome (PCOS) and T2DM. The main goal of our study was to investigate the role of Chemerin rs17173608 gene polymorphism in T2DM (type 2 diabetes mellitus). Materials and methods: 100 patients with T2DM and 50 healthy volunteers were included in the present study. DNA isolation from blood samples was performed with K1820-02 DNA Mini Kit. Chemerin gene polymorphism was detected by Tetra- Amplification Refractory mutation system polymerase chain reaction (T-ARMS-PCR). At the end of T-ARMS-PCR, samples were run using gel electrophoresis. Some samples were validated by sequence analysis. Results: In the genotype analysis, 18.0% of patients had TT genotype and 81.0% of TG genotype was detected. GG genotype was not detected in any patient. Genotype of 1 patient was unidentified. Genotype distribution of healthy control group was 12.0% TT genotype and 88.0% TG genotype. Similar to the T2DM group, the GG genotype was not detected in the control group. There was no statistically significant difference between T2DM group and healthy control group for TG and TT genotypes. Conclusion: To our knowledge, chemerin rs17173608 gene polymorphism has been investigated in T2DM for the first time herein. In the present study, the TT genotype ratios were higher in the T2DM subjects than in healthy subjects. G allele frequency in the T2DM group was lower than that in the control group. However, there was no statistically significant difference between the groups.

Download Full-text

Positive correlation between cognitive impairment and renal microangiopathy in patients with type 2 diabetic nephropathy: a multicenter retrospective study

Journal of International Medical Research ◽

10.1177/0300060518789299 ◽

2018 ◽

Vol 46 (12) ◽

pp. 5040-5051 ◽

Cited By ~ 2

Author(s):

Jinyu Li ◽

Jiamin Pan ◽

Bohan Li ◽

Huiyu Tian ◽

Ying Zhu ◽

...

Keyword(s):

Diabetic Nephropathy ◽

Cognitive Impairment ◽

Cognitive Function ◽

Correlation Analysis ◽

Pearson Correlation ◽

Control Group ◽

Positive Correlation ◽

Pearson Correlation Analysis ◽

Type 2 Diabetic

Objective This study was performed to explore the correlation between cognitive impairment and renal microangiopathy in patients with type 2 diabetic nephropathy (T2DN) by detecting changes in cognitive function and cerebral metabolism in these patients with different stages of T2DN. Methods Prospectively maintained databases were reviewed from 2006 to 2017. Blood biochemical indexes and the urinary albumin excretion rate (UAER) were measured in all participants. Cognitive function was assessed by the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment Scale (MoCA). Cognitive impairment was the primary endpoint. Renal microangiopathy was the secondary endpoint. Pearson correlation analysis was used to assess correlations. Results Two hundred sixteen patients with type 2 diabetes mellitus (T2DM) were divided into three groups according to their UAER: T2DM without nephropathy (n=72), early T2DM with nephropathy (n=74), and the clinical stage of early T2DM with nephropathy (n=70). Healthy participants were selected as the normal control group (n=70). Pearson correlation analysis demonstrated that the total MMSE and MoCA score was negatively correlated with the UAER (r=−0.327) and positively correlated with the estimated glomerular filtration rate (r=0.428) in patients with T2DN. Conclusions The present study showed a positive correlation between cognitive impairment and renal microangiopathy in patients with T2DN.

Download Full-text

Measurements of Alterations in Bone Mineral Density, and Body Composition in a Group of Type-2 Diabetic Women

NeuroQuantology ◽

10.14704/nq.2021.19.7.nq21083 ◽

2021 ◽

Vol 19 (7) ◽

pp. 48-56

Author(s):

Khalid Ghanim Majeed ◽

Muthanna Hashim Dawood ◽

Ali Khairaldeen Mohialdeen

Keyword(s):

Body Composition ◽

Lumbar Spine ◽

Fat Mass ◽

Total Body Water ◽

The Body ◽

Healthy Control Group ◽

Control Group ◽

Healthy Control ◽

Total Body

Aim: To assess the body composition of fat mass, lean mass, visceral fat mass, and total body water in DM patients and compares their findings with a healthy control group. Material and Methods: A total of 86 people including 40 diabetes Mellitus type 2 matched for sex and age with 46 healthy control participated in the study. BMDs of the lumbar vertebrae and the hip regions like (total femur, femoral neck) were assessed using the DXA technique. The mean age of (DM) group was 59 ± 11.82 years, the height 1.55 ± 0.05 m., the weight 80.82 ± 13.25 kg, and BMI 33.81 ± 6.76 kg/m2. Results: The differences in measurements of the lumbar spine BMD (1.12 ± 0.13 g/cm2), total femur BMD (1.10± 0.17 g/cm2) neck of femur BMD (0.85± 0.35 g/cm2), and total BMD of the body (0.90± 0.06 g/cm2) were highly significant in healthy control group as compared to DM patients 0.84 ± 0.13 g/cm2, 0.99±0.15 g/cm2, 0.82± 0.24 g/cm2 and 0.79 ± 0.09 g/cm2 respectively. Conclusion: The results shows a highly significant in the lumbar spine, total femur, and total BMC, and not significant in the neck of the femur. The total body lean compartment was not significantly different between DM patients and healthy control women groups. The total body water compartment in the DM women group was highly significant lower different comparing with a healthy control group. The mathematical equations to predict total bone density in DM type 2 and healthy control women were calculated.

Download Full-text

QTc Interval and QT Dispersion in Patients with Thalassemia Major: Electrocardiographic (EKG) and Echocardiographic Evaluation

Clinical Medicine Insights Cardiology ◽

10.4137/cmc.s4472 ◽

2010 ◽

Vol 4 ◽

pp. CMC.S4472 ◽

Cited By ~ 4

Author(s):

Taysir S. Garadah ◽

Salah Kassab ◽

Najat Mahdi ◽

Ahmed Abu-Taleb ◽

Anwer Jamsheer

Keyword(s):

Statistical Significance ◽

Qt Dispersion ◽

Thalassemia Major ◽

Healthy Control Group ◽

Control Group ◽

Qtc Interval ◽

Pulsed Doppler ◽

Time Index ◽

Significant Difference ◽

Healthy Control

Background Doppler echocardiographic studies in patients with β-Thalassemia Major (β-TM) had shown different patterns of left ventricle (LV) systolic and diastolic dysfunctions. Aim This cross-sectional study was designed to study the LV systolic and diastolic function in patients with β-TM using Pulsed Doppler (PD) Echocardiogram and assess the QTc interval and QT dispersion (QTd) on 12 leads ECG. Method All patients were evaluated clinically as well as by echocardiography and 12 leads ECG. The study included patients with β-TM (n = 38, age 15.7 ± 8.9 years), compared with an age-matched healthy control group (n = 38, age 15.9 ± 8.9 years). Results In 38 patients with β-TM Compared with healthy control group, The QTc interval and the QTd dispersion on ECG were increased with no significant difference mode echo showed that β-TM patients have thicker LV septal wall index (0.659 ± 0.23 vs. 0.446 ± 0.219 cm/M2, P < 0.001), posterior wall index (0.659 ± 0.235 vs. 0.437 ± 0.214 cm/M2, P < 0.01), and larger LVEDD index is (3.99 ± 0.48 vs. 2.170 ± 0.57 cm/M2. P < 0.05). Pulsed Doppler showed high LV trans-mitral E wave velocity index (70.818 ± 10.139 vs. 57.532 ± 10.139, P < 0.05) and E/A ratio (1.54 vs.1.23, P < 0.01). The duration of deceleration time index (DT) and isovolumic relaxation time index (IVRT) were significantly shorter in patients with β-TM (150.234 ± 20.0.23 vs. 167.123 ± 167.123 ± 19.143 msec/M2, P < 0.01) and (60.647 ± 6.77 vs. 75.474 ± 5.83 msec/M2, P < 0.001), respectively. The tricuspid valve velocity in patients with β-TM was significantly higher than controls (2.993 ± 0.569 vs. 1.93 ± 0.471 m/sec, respectively, P < 0.01), with calculated pulmonary artery pressure of 2.4 times the control (36.0 vs. 14.8 mmHg). However, the LVEF% or fractional shortening were not significantly different. Conclusion In this study, β-thalassemia major patients compared with controls have differences of QT dispersion and corrected QT interval that is of no statistical significance. A significantly thicker LV wall and LV diastolic filling indices are suggestive of restrictive diastolic pattern. These data indicate that LV diastolic abnormalities compromised initially in patients with β-thalassemia major.

Download Full-text

Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer

World Journal of Surgical Oncology ◽

10.1186/s12957-021-02395-z ◽

2021 ◽

Vol 19 (1) ◽

Author(s):

Wenwen Han ◽

Xiangzhen Bu ◽

Yanli Liu ◽

Fang Liu ◽

Yujie Ren ◽

...

Keyword(s):

Gastric Cancer ◽

Computed Tomography ◽

Correlation Analysis ◽

Healthy Control Group ◽

Control Group ◽

Clinical Value ◽

Healthy Control ◽

Pearson's Correlation ◽

Combined Detection ◽

Multi Detector Computed Tomography

Abstract Background To study the clinical value of miR-135 and miR-20a combined with multi-detector computed tomography (MDCT) in the diagnosis of gastric cancer (GC). Method A total of 146 patients with GC admitted to our hospital from January 2017 to June 2019 were selected and enrolled in the GC group. Another 103 patients with gastritis received in the same period were selected for the non-GC group. Besides, 95 healthy subjects who received physical examination in our hospital were selected into the healthy control group. Real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of serum miR-135 and miR-20a for each group. MDCT was used for detecting the clinical staging map of the enrolled patients. Pearson’s correlation analysis was used to analyze the correlation between serum miR-135 and miR-20a in patients with GC. The receiver operating characteristic (ROC) curve was drawn to analyze value of miR-135 and miR-20a in the diagnosis of GC. Results Compared with non-GC group and healthy control group, the levels of serum miR-135 and miR-20a increased significantly in the GC group, while no significant difference was found between non-GC group and healthy control group (P > 0.05). Analysis of the relationship with clinical characteristics showed that the expression of serum miR-135 and miR-20a in the GC group was significantly correlated with the progression of GC, TNM stage, degrees of differentiation, status of lymph node metastasis, and distant metastasis (P < 0.01). Pearson’s correlation analysis results showed positive correlations between miR-135 and miR-20a (r = 0.634, P = 0.000). The ROC analysis results showed that the optimal diagnostic values of miR-135 and miR-20a for GC were 7.56 and 5.82 respectively. The area under the curve (AUC) was 0.873 and 0.793 respectively. The 95% confidence interval (CI) was 0.811-0.935 and 0.697-0.890 respectively. The sensitivity and specificity of miR-135 and miR-20a combined with MDCT in the diagnosis of GC were 90.41% and 93.20% respectively. The sensitivity of combined use was significantly higher than that of single detection (P < 0.01). Conclusion There are high expression levels of serum miR-135 and miR-20a in patients with GC. A combined detection of miR-135 and miR-20a with MDCT can improve the diagnostic sensitivity of GC and improve the accuracy of the final diagnosis. Therefore, multiple combined detection is valuable in the diagnosis of GC.

Download Full-text

Metabolic syndrome and C-reactive protein in patients with depressive disorder on antidepressive medication

Srpski arhiv za celokupno lekarstvo ◽

10.2298/sarh1308511s ◽

2013 ◽

Vol 141 (7-8) ◽

pp. 511-515 ◽

Cited By ~ 3

Author(s):

Albina Stanojevic ◽

Irena Popovic ◽

Milutin Nenadovic ◽

Dragan Ravanic ◽

Gordana Paunovic-Milosavljevic

Keyword(s):

Metabolic Syndrome ◽

Depressive Disorder ◽

Total Cholesterol ◽

Healthy Control Group ◽

Control Group ◽

C Reactive Protein ◽

Reactive Protein ◽

Cholesterol Levels ◽

Healthy Control ◽

Experimental Group

Introduction. Recurrent depression is a psychiatric disorder of which etiology and pathogenesis might be related to immune response. Metabolic Syndrome (MetS) and its components are also strongly associated with elevated inflammatory indicators, as so as the body mass index (BMI) and total cholesterol levels. Objective. Objective of this study was to investigate if there was any difference in C-reactive protein (CRP) levels in patients with recurrent depressive disorder, treated with antidepressants, compared to a healthy control group of subjects and if there was an association between increased CRP levels and the presence of MetS in these two groups. Methods. Sixty subjects entered the study; of these 35 patients with the diagnosis of recurrent depressive disorder, while the healthy control group included 25 subjects. MetS was defined according to the NCEP ATP III criteria. The cut-off point for CRP was set at >5 mg /L. Results. There was no statistically significant difference in the prevalence of MetS and CRP values between the studied groups. Waist circumference and total cholesterol levels were significantly higher in the experimental group. Patients that fulfilled the criteria for MetS showed significantly higher values of central obesity and arterial hypertension in the experimental group as well. The elevated CRP levels were associated with increased frequency of MetS in depressed patients. Conclusion. Both CRP levels and metabolic risk profile screening, according to the international criteria, may be beneficial in order to obtain better assessment for depressive long term medicated patients.

Download Full-text

Association of Irisin Circulating Level with Diabetic Retinopathy: A Case-Control Study

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/a-0723-3749 ◽

2018 ◽

Vol 129 (01) ◽

pp. 36-42 ◽

Cited By ~ 1

Author(s):

Nafez Abu Tarboush ◽

Nakhleh E Abu-Yaghi ◽

Laith H Al Ejeilat ◽

Rawand K. Abdel Wahed ◽

Issa N Jeris

Keyword(s):

Type 2 Diabetes ◽

Diabetic Retinopathy ◽

Positive Control ◽

Control Group ◽

Diabetes Group ◽

Healthy Control ◽

Diabetes Development ◽

Study Participants ◽

Control Study

AbstractObesity and obesity induced type 2 diabetes development and progression have been associated with sedentary lifestyle. Irisin, a newly discovered myokine, has been demonstrated at lower levels in obese and type 2 diabetes patients compared to controls. The main aim of this study is to explore association of Irisin with diabetic retinopathy (DR). A total of 233 healthy and adults participated in this study. Participants were divided into four categories: a healthy control group and an age-match subset of patients with type 2 diabetes; a positive control group of patients with type 2 diabetes not affected by DR (No DR); and patients with type 2 diabetes affected by DR (non-proliferative DR (NPDR) and proliferative DR (PDR)). Plasma samples were quantified for Irisin measurement, lipid profile and HbA1c. Comparison of the age-matched groups of healthy controls and patients with type 2 diabetes revealed lower Irisin plasma level in type 2 diabetes group. Analyses revealed negative correlations of Irisin to HbA1c and LDL levels and positive correlation to HDL level. Comparing Irisin level in No DR and DR groups revealed a higher level in No DR group and analysis per DR classification indicated higher Irisin level in NPDR group. Our results demonstrate not only correlation of plasma Irisin level with DR stages, but also significantly different Irisin level among them. This is promising in terms of researching Irisin as a potential associating marker for type 2 diabetes and DR development and progression.

Download Full-text

Organic Volatile Compounds Used in Type 2 Diabetes

10.5772/intechopen.94752 ◽

2020 ◽

Author(s):

Mioara Petrus ◽

Cristina Popa ◽

Ana-Maria Bratu

Keyword(s):

Type 2 Diabetes ◽

Metabolic Diseases ◽

Gas Analysis ◽

Healthy Control Group ◽

Control Group ◽

Exhaled Breath ◽

Glucose Levels ◽

Close Relationship ◽

Healthy Control

Analysis of volatile organic compounds (VOCs) in exhaled breath is non-invasive method and appears as a promising tool for metabolic monitoring. Diabetes is a complex syndrome, metabolic diseases that is characterized by hyperglycemia associated with major changes in lipids and proteins. The pathophysiology of the link between diabetes, hypertension, inflammatory syndrome and oxidative stress is complex. We conducted a study and applied quantitative analysis of exhaled ethylene and ammonia in patients with type 2 diabetes mellitus (T2DM) and a healthy control group. For breath gas analysis, a very sensitive CO2 laser photoacoustic spectroscopy (CO2LPAS) was applied. The concentration of exhaled VOCs differed between T2DM patients and healthy group, in particular, T2DM patients exhaled significantly higher amounts of ethylene and ammonia compared to healthy control group. The data obtained by the CO2LPAS system revealing that the increased breath VOCs has a close relationship with high glucose levels and with healthy complications.

Download Full-text

Vitamin D Treatment in Patients with Hashimoto’s Thyroiditis may Decrease the Development of Hypothyroidism

International Journal for Vitamin and Nutrition Research ◽

10.1024/0300-9831/a000269 ◽

2016 ◽

Vol 86 (1-2) ◽

pp. 9-17 ◽

Cited By ~ 3

Author(s):

Bekir Ucan ◽

Mustafa Sahin ◽

Muyesser Sayki Arslan ◽

Nujen Colak Bozkurt ◽

Muhammed Kizilgul ◽

...

Keyword(s):

Vitamin D ◽

Vitamin D Deficiency ◽

Hashimoto’S Thyroiditis ◽

Healthy Control Group ◽

Hashimoto's Thyroiditis ◽

Control Group ◽

Endocrine Society ◽

Thyroid Autoantibody ◽

Healthy Control ◽

The Mean

Abstract.The relationship between Hashimoto’s thyroiditis and vitamin D has been demonstrated in several studies. The aim of the present study was to evaluate vitamin D concentrations in patients with Hashimoto’s thyroiditis, the effect of vitamin D therapy on the course of disease, and to determine changes in thyroid autoantibody status and cardiovascular risk after vitamin D therapy. We included 75 patients with Hashimoto’s thyroiditis and 43 healthy individuals. Vitamin D deficiency is defined as a 25-hydroxy vitamin D (25(OH)D3) concentration less than 20ng/mL. Vitamin D deficient patients were given 50.000 units of 25(OH)D3 weekly for eight weeks in accordance with the Endocrine Society guidelines. All evaluations were repeated after 2 months of treatment. Patients with Hashimoto’s thyroiditis had significantly lower vitamin D concentrations compared with the controls (9.37±0.69 ng/mL vs 11.95±1.01 ng/mL, p < 0.05, respectively). Thyroid autoantibodies were significantly decreased by vitamin D replacement treatment in patients with euthyroid Hashimoto’s thyroiditis. Also, HDL cholesterol concentrations improved in the euthyroid Hashimoto group after treatment. The mean free thyroxine (fT4) concentrations were 0.89±0.02 ng/dL in patients with Hashimoto’s thyroiditis and 1.07±0.03 ng/dL in the healthy control group (p < 0.001). The mean thyroid volumes were 7.71±0.44 mL in patients with Hashimoto’s thyroiditis and 5.46±0.63 mL in the healthy control group (p < 0.01). Vitamin D deficiency is frequent in Hashimoto’s thyroiditis and treatment of patients with this condition with Vitamin D may slow down the course of development of hypothyroidism and also decrease cardiovascular risks in these patients. Vitamin D measurement and replacement may be critical in these patients.

Download Full-text